Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Cancer Immunology, Immunotherapy : CII|May 21, 2022
Treatment with a retinoic acid-inducible gene I (RIG-I) agonist as monotherapy and in combination with pembrolizumab in patients with advanced solid tumors: results from two phase 1 studiesV Moreno, E Calvo, M R Middleton, et al.
The British Journal of Radiology|June 19, 2008
High-intensity focused ultrasound ablation of liver tumours: can radiological assessment predict the histological response?T A Leslie, J E Kennedy, R O Illing, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 15, 2018
Paclitaxel with or without trametinib or pazopanib in advanced wild-type BRAF melanoma (PACMEL): a multicentre, open-label, randomised, controlled phase II trialV Urbonas, D Schadendorf, L Zimmer, et al.
British Journal of Cancer|April 16, 2009
A phase I study of extended dosing with lomeguatrib with temozolomide in patients with advanced melanomaR F Kefford, N P B Thomas, P G Corrie, et al.
Journal of Medicinal Chemistry|December 19, 1998
Inactivation of O6-alkylguanine-DNA alkyltransferase. 1. Novel O6-(hetarylmethyl)guanines having basic rings in the side chainR S McElhinney, D J Donnelly, J E McCormick, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 12, 2007
A phase I and pharmacokinetic study of lapatinib in combination with infusional 5-fluorouracil, leucovorin and irinotecanR S Midgley, D J Kerr, K T Flaherty, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 26, 2014
DOC-MEK: a double-blind randomized phase II trial of docetaxel with or without selumetinib in wild-type BRAF advanced melanomaA Gupta, S Love, A Schuh, et al.
British Journal of Cancer|February 18, 2011
A phase I study of the safety and tolerability of olaparib (AZD2281, KU0059436) and dacarbazine in patients with advanced solid tumoursO A Khan, M Gore, P Lorigan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 24, 2015
Randomized phase II study evaluating veliparib (ABT-888) with temozolomide in patients with metastatic melanomaM R Middleton, P Friedlander, O Hamid, et al.
British Journal of Cancer|April 16, 2009
O(6)-methylguanine-DNA methyltransferase depletion and DNA damage in patients with melanoma treated with temozolomide alone or with lomeguatribA J Watson, M R Middleton, G McGown, et al.
Pageof 6